Financials

  • Market Capitalization 9.52 B
  • Employee 673
  • Founded 1997
  • CEO Robert I. BlumRobert I. Blum
  • Website www.cytokinetics.com
  • Headquarter California, United States
  • FIGI BBG000F0R4N9
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.72
Relación precio/flujo de caja
0.09

Cytokinetics, Incorporated - Common Stock

Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

Noticias